Independent research on the U.S. markets, Baptista Research

Baptista Research

Independent research on the U.S. markets

Baptista Research is an independent financial research house focused on the U.S. markets. We provide equity research as well as credit research reports on the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms. We operate a research subscription service where institutions, as well as retail investors, can have priority access to all our research. We also have a wide distribution of our research reports across some of the top global financial platforms. Apart from equity research and credit research, we also provide advisory services with respect to mergers & acquisitions (M&A), private equity/ venture capital fundraising, valuation reports, and investment management services for corporates.
Baptista Research is owned and managed by Ishan Majumdar, an ex-Venture Capitalist/ Investment Banker, a Chartered Accountant, and a Masters’ degree holder in Management from HEC Paris. Ishan has nearly a decade of experience in Mergers and Acquisitions, Leveraged Buyouts (LBOs), Venture Capital Investing, Corporate Strategy, and Valuation in front-office roles at the likes of BNP Paribas CIB, Credit Agricole CIB, Groupe Danone, and TIW Private Equity. He has worked on and closed multiple acquisition deals, leveraged buyouts, and start-up investment transactions.

Equity Bottom-Up

<ul><li>HCA Healthcare's third-quarter performance for 2025 has shown strong results year-over-year, with a notable 42% increase in diluted earnings per share, as adjusted.</li><li>The revenue grew by 9.6%, driven by broad-based volume growth and an improved payer mix.</li><li>This improvement, coupled with disciplined operational management, resulted in better margins.</li></ul>

HCA Healthcare's third-quarter performance for 2025 has shown strong results year-over-year, with a notable 42% increase in diluted earnings per share, as adjusted.The revenue grew by 9.6%, driven by broad-based volume growth and an improved payer mix.This improvement, coupled with disciplined operational management, resulted in better margins.

HCA Healthcare: What Is The Expected Impact Of The Elevated Medical Utilization Trends?

<ul><li>HCA Healthcare's latest financial results for the second quarter of 2025 demonstrated robust performance, characterized by a notable 24% increase in diluted earnings per share as adjusted.</li><li>The revenue growth of 6.4% was a key highlight, driven by a mixture of increased service demand, an improved payer mix, and stable patient acuity levels.</li><li>From an operational standpoint, HCA Healthcare experienced a stable environment that contributed to enhanced margins.</li></ul>

HCA Healthcare's latest financial results for the second quarter of 2025 demonstrated robust performance, characterized by a notable 24% increase in diluted earnings per share as adjusted.The revenue growth of 6.4% was a key highlight, driven by a mixture of increased service demand, an improved payer mix, and stable patient acuity levels.From an operational standpoint, HCA Healthcare experienced a stable environment that contributed to enhanced margins.

HCA Healthcare Power Move: How $5.5 Billion in Projects Is Reinforcing Its Market Position!

<ul><li>HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position.</li><li>The company recorded strong financial results based on consistent volume growth, an improved payer mix, and increased operating margin.</li><li>Diluted earnings per share also saw a notable 20% increase, reaching $6.45.</li></ul>

HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position.The company recorded strong financial results based on consistent volume growth, an improved payer mix, and increased operating margin.Diluted earnings per share also saw a notable 20% increase, reaching $6.45.

HCA Healthcare: An Insight Into The Labor Market Dynamics & Wage Trends & Vital Factors Driving Growth!

<ul><li>HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the period.</li><li>Positively, the company continued to demonstrate robust demand for healthcare services, with an overall revenue growth of approximately 6% compared to the previous year.</li><li>Key performance indicators like inpatient admissions showed a healthy upward trajectory, with a 3% increase in both categories when measured on a same-facility basis.</li></ul>

HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the period.Positively, the company continued to demonstrate robust demand for healthcare services, with an overall revenue growth of approximately 6% compared to the previous year.Key performance indicators like inpatient admissions showed a healthy upward trajectory, with a 3% increase in both categories when measured on a same-facility basis.

HCA Healthcare’s New Revenue Strategy: Inside The Government Policies & Critical Factors Powering Its Growth!

<ul><li>HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters.</li><li>The company displayed resilience amidst challenges, such as significant weather disruptions caused by hurricanes, and a stable operational environment underpinned a reasonable starting point for 2025.</li><li>The execution of efficient operational strategies has allowed the organization to stabilize operations in affected regions like North Carolina, Georgia, and West Florida.</li></ul>

HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters.The company displayed resilience amidst challenges, such as significant weather disruptions caused by hurricanes, and a stable operational environment underpinned a reasonable starting point for 2025.The execution of efficient operational strategies has allowed the organization to stabilize operations in affected regions like North Carolina, Georgia, and West Florida.

HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! - Major Drivers

United States

HCA Healthcare, Inc.  operates hospitals.  The Company operates acute care hospitals, outpatient facilities, clinics and other patient care delivery settings.  HCA operates hospitals in the United States and the United Kingdom.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

HCA Healthcare, Inc. (HCA US)

HCA Healthcare: What Is The Expected Impact Of The Elevated Medical Utilization Trends?

HCA Healthcare's third-quarter performance for 2025 has shown strong results year-over-year, with a notable 42% increase in diluted earnings per...

Baptista Research

HCA Healthcare Power Move: How $5.5 Billion in Projects Is Reinforcing Its Market Position!

HCA Healthcare's latest financial results for the second quarter of 2025 demonstrated robust performance, characterized by a notable 24% increase...

Baptista Research

HCA Healthcare: An Insight Into The Labor Market Dynamics & Wage Trends & Vital Factors Driving Growth!

HCA Healthcare's recent earnings call for Q1 2025 presents a nuanced picture of the company's performance and strategic position. The company...

Baptista Research

HCA Healthcare’s New Revenue Strategy: Inside The Government Policies & Critical Factors Powering Its Growth!

HCA Healthcare delivered a mixed performance in its fourth-quarter 2024 results, reflecting both strengths and challenges faced during the...

Baptista Research

HCA Healthcare: Health Insurance Exchange Growth Driving Our ‘Outperform’ Rating! - Major Drivers

HCA Healthcare concluded the fourth quarter of 2024 with robust business fundamentals, maintaining consistency with previous quarters. The company...

Baptista Research

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)